Correlation between CXCR4/CXCR7/CXCL12 chemokine axis expression and prognosis in lymph‐node‐positive lung cancer patients. Issue 1 (9th November 2017)

• Record Type: Journal Article
• Authors: Katsura, Masakazu; Shoji, Fumihiro; Okamoto, Tatsuro; Shimamatsu, Shinichiro; Hirai, Fumihiko; Toyokawa, Gouji; Morodomi, Yosuke; Tagawa, Tetsuzo; Oda, Yoshinao; Maehara, Yoshihiko
• Is Part Of: Cancer science. Volume 109:Issue 1(2018)
• Page Start: 154
• Page End: 165
• Publication Date: 2017-11-09
• Subjects: CXCL12 -- CXCR4 -- CXCR7 -- metastatic lymph nodes -- non‐small‐cell lung cancer; Cancer -- Periodicals; Neoplasms -- Periodicals; Research -- Periodicals; Electronic journals; 616.994005
• DOI: 10.1111/cas.13422
• Languages: English
• ISSNs: 1347-9032

Abstract

Abstract : The CXCR4/CXCR7/CXCL12 chemokine axis plays important roles in the migration of tumor cells during cancer development by modulating site‐specific distant metastasis including to regional lymph nodes. We investigated the correlation of these chemokine expressions to prognosis in lymph‐node‐positive non‐small‐cell lung cancer (NSCLC) patients. A total of 140 surgically resected specimens of primary site (PS) and metastatic lymph nodes (MLN) of NSCLC involving hilar and/or mediastinal lymph nodes (N1‐2) were collected. CXCR4, CXCR7 and CXCL12 expressions were evaluated. Cox regression analysis was performed to determine whether these chemokines were independent prognostic factors in N1‐2 NSCLC. High expression of CXCR4 in PS and CXCL12 in MLN was associated with poor overall survival (OS) ( P = .025 and .033, respectively). Significant correlations between CXCR4 expression in PS and CXCL12 expression in MLN were observed ( P = .040). There was significant difference in OS between 2 groups according to expressions of CXCR4 in PS and CXCL12 in MLN ( P = .0033). Expression of CXCL12 in MLN was identified as an independent prognostic factor (HR 1.79, 95% CI 1.08‐3.04, P = .023). CXCL12 in MLN was mainly expressed by tumor cells compared with stromal cells (56% vs 25%, respectively, P < .0001). CXCR4/CXCL12 may play roles in tumor progression in MLN and is associated with poor prognosis of lymph‐node‐positive NSCLC patients. Abstract : CXCR4/CXCR7/CXCL12 chemokine axis plays important roles in the migration of cancer cells during cancer development. We investigated the correlation of these chemokine expressions to prognosis in lymph‐node‐positive non‐small‐cell lung cancer (NSCLC) patients. CXCR4/CXCL12 may play roles in tumor progression in MLN and are associated with poor prognosis of lymph‐node‐positive NSCLC patients.